Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-09 4:10 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | GV 2016 L.P. | 208,697 1.400% | 208,697 (New Position) | View |
2023-02-27 4:04 pm Purchase | 13G | STARCO BRANDS, INC. CLASS A CO STCB | GV 2016 L.P. | 57,535,013 12.400% | 57,535,013 (New Position) | View |
2022-04-22 4:16 pm Sale | 13G | IONQ INC IONQ | GV 2016 L.P. | 4,556,532 2.300% | -17,350,506 (-79.20%) | View |
2022-02-14 12:32 pm Sale | 13G | Desktop Metal Inc. DM | GV 2016 L.P. | 11,048,730 3.550% | -3,253,708 (-22.75%) | View |
2022-02-14 12:32 pm Unchanged | 13G | IONQ INC IONQ | GV 2016 L.P. | 21,907,038 11.380% | 0 (Unchanged) | View |
2022-02-14 12:30 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | GV 2016 L.P. | 2,563,441 3.650% | -2,486,345 (-49.24%) | View |
2022-02-14 12:30 pm Purchase | 13G | Decibel Therapeutics Inc. DBTX | GV 2016 L.P. | 1,636,258 6.570% | 1,636,258 (New Position) | View |
2021-10-12 5:25 pm Purchase | 13G | IONQ INC IONQ | GV 2016 L.P. | 21,907,038 11.380% | 21,907,038 (New Position) | View |
2021-02-10 4:49 pm Sale | 13G | ATERIAN INC ATER | GV 2016 L.P. | 0 0.000% | -1,055,954 (Position Closed) | View |
2021-02-10 4:38 pm Purchase | 13G | Desktop Metal Inc. DM | GV 2016 L.P. | 14,302,438 6.310% | 14,302,438 (New Position) | View |
2020-02-13 4:09 pm Purchase | 13G | ATERIAN INC ATER | GV 2016 L.P. | 1,055,954 5.960% | 1,055,954 (New Position) | View |